Format

Send to

Choose Destination
Transpl Int. 2020 Feb;33(2):244-246. doi: 10.1111/tri.13560. Epub 2019 Dec 13.

Ruxolitinib for steroid-refractory acute graft-versus-host disease.

Author information

1
University of Minnesota, Minneapolis, MN, USA.
2
Department of Medicine, Division of Oncology, Washington University School of Medicine in Saint Louis, Saint Louis, MO, USA.
PMID:
31755139
DOI:
10.1111/tri.13560

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center